Bubby-no dilemma. Edison spruiked 2 new distribution/marketing partnership agreements by year end to bring mkt cap to $100 mil. One so far & SP down 30%. Next within 6 wks worth +$80 mil valuation....can't waitGood luck influencing mgmt. AGM was opportunity & exec decisions supported by SH vote, incl cap raise. Prepare your fury & sell orders.
Agree znew. Pipeline regardless, some of the worst mgmt performance indicators & comms in sector.
With SP tanked -55% (now 65%) & impressive destruction of SH value & mtk cap...this co mgmt then awarded CEO and CSO (ex-CEO) very large cash + options performance bonuses(!?) Taking $ off the table with short cash runway, investors hammered & need to tap mkt w/ another cap raise. Appalling & says much about "improving investor confidence/sentiment & giving something back to investors".
Best SH option now IP/pipeline buyout by well capitalised competent mgmt. If co employees assigned invention rights & co owns IP....
- Forums
- ASX - By Stock
- Ann: Patent granted for allogeneic stem cell technology platform
Bubby-no dilemma. Edison spruiked 2 new distribution/marketing...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CMB (ASX) to my watchlist
|
|||||
Last
41.0¢ |
Change
0.010(2.50%) |
Mkt cap ! $4.891M |
Open | High | Low | Value | Volume |
41.0¢ | 41.0¢ | 41.0¢ | $52 | 127 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 1750 | 41.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
50.0¢ | 14500 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 1750 | 0.415 |
4 | 16374 | 0.400 |
1 | 2500 | 0.200 |
1 | 5000 | 0.100 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.500 | 14500 | 1 |
0.545 | 13403 | 1 |
0.000 | 0 | 0 |
0.000 | 0 | 0 |
0.000 | 0 | 0 |
Last trade - 11.00am 19/07/2024 (20 minute delay) ? |
Featured News
CMB (ASX) Chart |